Papers
24
Total Citations
431
H-Index
10
About
Jakko A. Nieuwenhuijzen is a leading urologic oncologist whose research centers on improving the staging and surgical management of prostate cancer, particularly through the integration of advanced molecular imaging. His major contributions lie in validating the clinical utility of PSMA PET/CT, especially the 18F-DCFPyL tracer, for detecting pelvic lymph-node metastases. His landmark SALT trial (106 citations) demonstrated the superior accuracy of PSMA PET/CT over conventional imaging for nodal staging, while the DeTeCT trial (47 citations) explored its potential for guiding targeted biopsies. Nieuwenhuijzen has also developed and externally validated a novel nomogram (35 citations) that combines MRI and PSMA PET data to predict lymph-node involvement, offering a powerful tool for clinical decision-making. Beyond diagnostics, his work includes refining surgical techniques for urinary continence reconstruction in robot-assisted radical prostatectomy and investigating focal laser ablation. His research consistently shows high impact, with multiple papers exceeding 20 citations, and has directly influenced how clinicians stage prostate cancer, potentially sparing many patients from unnecessary extended pelvic lymph-node dissections.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10